ClinicalTrialsFinder

Metastatic Adrenal Cortical Carcinoma Clinical Trials in Pittsburgh, Pennsylvania

1 recruitingPittsburgh, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 2

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more
National Cancer Institute (NCI)48 enrolled65 locationsNCT06900595